IMMUNOGEN INC·4

Feb 4, 4:35 PM ET

McKee Blaine H. 4

4 · IMMUNOGEN INC · Filed Feb 4, 2019

Insider Transaction Report

Form 4
Period: 2019-01-31
McKee Blaine H.
EVP & Chief Business Officer
Transactions
  • Award

    Stock Option (right to buy)

    2019-01-31$5.25/sh+173,140$908,985173,140 total
    Exercise: $5.25From: 2020-01-31Exp: 2029-01-31Common Stock (173,140 underlying)
Footnotes (1)
  • [F1]Exercisable in three equal installments over three years starting on the first year anniversary of the grant.

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -